Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
PLoS One ; 13(3): e0194449, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29584748

RESUMEN

Three iridoids (lamalbid (I1), sesamoside (I2) and shanzhiside methyl ester (I3)) and seven polyphenols (cistanoside F (P1), chlorogenic acid (P2), pedalitin-6-O-laminaribioside (P3), pedaliin (P4), isoacteoside (P6), pedalitin (P7) and martynoside (P8)) were identified in young sesame leaves (Sesamum indicum L.) other than the acteoside (P5) reported previously. P3 was a new compound, and I1, I3, P2 and P8 were found in a species of Sesamum for the first time. HPLC analyses revealed that the compounds I1 (0.29-1.75% of dry leaves), I2 (0.38-0.87%), I3 (0.04-1.07%), P4 (0.01-2.05%) and P5 (0.13-4.86%) were present primarily in young sesame leaves and were found in plants cultivated on different farms (plant height, 30-70 cm). Of the identified compounds, P5 and P6 showed high 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging, oxygen radical absorbance capacity (ORAC), and in vitro antiglycation activities. Given its content, P5 makes a major contribution to the biological activities of young sesame leaves. The compounds were examined at six different growth stages of plants cultured in a greenhouse to determine the optimum harvest stage and for end-use assessment. P5 accumulated in the leaves during growth, and the content reached a maximum of 12.9% of dry leaves in the 4th stage (plant height, 74.5±9.7 cm), which is one of the highest percentages reported in plants from nature.


Asunto(s)
Antioxidantes/análisis , Hojas de la Planta/crecimiento & desarrollo , Polifenoles/análisis , Sesamum/crecimiento & desarrollo , Animales , Antioxidantes/metabolismo , Bovinos , Hojas de la Planta/química , Polifenoles/metabolismo , Sesamum/química
2.
Neuropharmacology ; 52(3): 1055-64, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17196226

RESUMEN

The circadian pacemaker in the suprachiasmatic nucleus (SCN) generates the near 24-h period of the circadian rhythm and is entrained to the 24-h daily cycle by periodic environmental signals, such as the light/dark cycle (photic signal), and can be modulated by various drugs (non-photic signals). The mechanisms by which non-photic signals modulate the circadian clock are not well understood in mice. In mice, many reportedly non-photic stimuli have little effect on the circadian rhythm in vivo. Herein, we investigated the molecular mechanism in W-212393-induced phase advance using mice. W-212393 caused a significant phase advance of locomotor activity rhythm in mice at subjective day. Injection of W-212393 during subjective day elicited down-regulation of mPER2 protein in the SCN shell region, but not mPer2 mRNA. Administration of W-212393 during subjective day failed to produce phase advance in mPer2-mutant mice as well as in ORL1 receptor deficient mice. Furthermore, we show that such inhibition of mPER2 accelerates re-entrainment of the circadian clock following an abrupt shift in the environmental light/dark cycle, such as occurs with transmeridian flight. The present results suggest that post-translational down-regulation of mPER2 protein in the shell region of mouse SCN may be involved in W-212393-induced non-photic phase advance.


Asunto(s)
Proteínas de Ciclo Celular/metabolismo , Ritmo Circadiano , Regulación hacia Abajo/fisiología , Ambiente , Proteínas Nucleares/metabolismo , Receptores Opioides/fisiología , Núcleo Supraquiasmático/metabolismo , Factores de Transcripción/metabolismo , Acenaftenos/farmacología , Animales , Conducta Animal , Bencimidazoles/farmacología , Proteínas de Ciclo Celular/genética , Relación Dosis-Respuesta en la Radiación , Regulación hacia Abajo/efectos de los fármacos , Inmunohistoquímica/métodos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Actividad Motora/fisiología , Actividad Motora/efectos de la radiación , Mutación , Proteínas Nucleares/genética , Proteínas Circadianas Period , Estimulación Luminosa , ARN Mensajero/biosíntesis , Receptores Opioides/agonistas , Receptores Opioides/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Factores de Tiempo , Factores de Transcripción/genética , Receptor de Nociceptina
3.
J Neurosci ; 24(27): 6057-69, 2004 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-15240797

RESUMEN

Fibroblast growth factor receptor 1 (Fgfr1) is expressed at high levels by progenitor cells of the ventricular zone (VZ) within the hippocampal primordium. To investigate the role of Fgfr1 in these cells, in vivo Cre recombination of "floxed" Fgfr1 alleles was directed to cells of the radial glial lineage by using the human glial fibrillary acidic protein promoter. Radial glial-like cells of the hippocampal VZ are the progenitors of pyramidal neurons and granule cells of hippocampal dentate gyrus (DG). Mice carrying null Fgfr1 alleles (Fgfr1(Deltaflox)) in cells of this lineage showed a dramatic loss of Fgfr1 gene expression throughout the embryonic dorsal telencephalon. These Fgfr1(Deltaflox) mice exhibited a approximately 30% decrease in dividing radial glial progenitor cells in the hippocampal VZ and DG in the late embryonic period, progressing to a approximately 50-60% loss at birth, without any changes in cell survival. In addition, no FGF2-sensitive neural stem cells could be isolated from the Fgfr1(Deltaflox) hippocampal neuroepithelium, whereas epidermal growth factor-sensitive neural stem cells were not affected. The number of hippocampal pyramidal neurons and DG granule cells was approximately 30-50% decreased from the perinatal period through adulthood, and the number of parvalbumin-containing interneurons was similarly decreased in both the DG and pyramidal cell fields. We conclude that Fgfr1 is necessary for hippocampal growth, because it promotes the proliferation of hippocampal progenitors and stem cells during development.


Asunto(s)
Hipocampo/crecimiento & desarrollo , Hipocampo/fisiología , Proteínas Tirosina Quinasas Receptoras/fisiología , Receptores de Factores de Crecimiento de Fibroblastos/fisiología , Células Madre/metabolismo , Animales , Antígenos de Diferenciación/biosíntesis , Recuento de Células , Linaje de la Célula , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Trastornos Heredodegenerativos del Sistema Nervioso/epidemiología , Trastornos Heredodegenerativos del Sistema Nervioso/genética , Trastornos Heredodegenerativos del Sistema Nervioso/patología , Trastornos Heredodegenerativos del Sistema Nervioso/fisiopatología , Hipocampo/embriología , Humanos , Hibridación in Situ , Ventrículos Laterales/citología , Ventrículos Laterales/embriología , Ventrículos Laterales/fisiología , Ratones , Ratones Transgénicos , Mutagénesis Sitio-Dirigida , Neuroglía/citología , Neuroglía/metabolismo , Neuronas/citología , Células Piramidales/citología , ARN Mensajero/biosíntesis , Proteínas Tirosina Quinasas Receptoras/genética , Proteínas Tirosina Quinasas Receptoras/farmacología , Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos , Receptores de Factores de Crecimiento de Fibroblastos/genética , Células Madre/citología , Células Madre/efectos de los fármacos , Transgenes
4.
Biochem Biophys Res Commun ; 354(3): 752-6, 2007 Mar 16.
Artículo en Inglés | MEDLINE | ID: mdl-17254554

RESUMEN

Lithium is one of the most commonly used drugs in the prophylaxis and treatment of bipolar disorder. It is also known to lengthen circadian period in several organisms. Previously, we reported that there was the association between lengthening circadian period by lithium and GSK-3 protein and its enzyme activity in the mouse suprachiasmatic nucleus (SCN). In this study, we show that lithium affects the circadian oscillator in young and old hamster SCN, in an age-dependent manner. We found that basal levels of phosphorylated GSK-3 (pGSK-3) protein expression in old hamsters are much lower than that in young hamsters. Furthermore, in the old hamsters, lithium did not affect the period of the locomotor activity rhythm or pGSK-3 expression, while changing period and pGSK-3 in the younger animals. These results indicate that the content of pGSK-3 in the SCN has an important role in age-dependent effects of lithium on the circadian oscillator.


Asunto(s)
Envejecimiento/fisiología , Ritmo Circadiano/efectos de los fármacos , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Glucógeno Sintasa Quinasa 3/metabolismo , Litio/farmacología , Núcleo Supraquiasmático/efectos de los fármacos , Animales , Trastorno Bipolar/tratamiento farmacológico , Ritmo Circadiano/fisiología , Cricetinae , Regulación Enzimológica de la Expresión Génica/fisiología , Glucógeno Sintasa Quinasa 3/genética , Masculino , Núcleo Supraquiasmático/metabolismo , Factores de Tiempo
5.
Eur J Neurosci ; 19(8): 2281-7, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15090054

RESUMEN

A circadian clock located in the suprachiasmatic nucleus (SCN) regulates the period of physiological and behavioural rhythms to approximately 24 h. Lithium can lengthen the period of circadian rhythms in most organisms although little is known about the underlying mechanism. In the present study, we examined Drosophila shaggy ortholog glycogen synthase kinase-3 (GSK-3) protein expression in the SCN after lithium treatment. When locomotor activity was assessed, we found an association between the effect of lithium and the period of circadian oscillation as well as the level of GSK-3 protein expression. The decreased expression of GSK-3 and increased expression of phosphorylated GSK-3 (pGSK-3) resulted in an antiphasic circadian rhythm between the two in the SCN of lithium-treated mice housed under both light-dark and constant dark conditions. The enzyme activity of GSK-3 in the SCN was low when the level of pGSK-3 protein was high, as examined by immunoblotting analysis. Thus, GSK-3 enzyme activity has a correlation with the expression of GSK-3 protein in the SCN. Although both GSK-3 and pGSK-3 proteins are also expressed in the arcuate nucleus, lithium did not affect their expression. Based on the association that we found between lengthened circadian period and GSK-3 protein and GSK-3 activity in the SCN, we suggest that GSK-3 plays a role in regulating the period of the mammalian circadian pacemaker.


Asunto(s)
Ritmo Circadiano/efectos de los fármacos , Glucógeno Sintasa Quinasa 3/biosíntesis , Carbonato de Litio/farmacología , Actividad Motora/efectos de los fármacos , Núcleo Supraquiasmático/efectos de los fármacos , Animales , Ritmo Circadiano/fisiología , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Regulación Enzimológica de la Expresión Génica/fisiología , Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores , Masculino , Ratones , Ratones Endogámicos C57BL , Actividad Motora/fisiología , Núcleo Supraquiasmático/enzimología , Regulación hacia Arriba/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA